|
DLEU2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.732300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.278000E-01 |
| Normal-vs-Stage2 |
2.525000E-01 |
| Normal-vs-Stage3 |
7.602300E-03 |
| Normal-vs-Stage4 |
4.657200E-03 |
| Stage1-vs-Stage2 |
5.814000E-01 |
| Stage1-vs-Stage3 |
3.213800E-02 |
| Stage1-vs-Stage4 |
6.959200E-03 |
| Stage2-vs-Stage3 |
2.157800E-01 |
| Stage2-vs-Stage4 |
2.867200E-01 |
| Stage3-vs-Stage4 |
5.751800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.136020E-01 |
| Normal-vs-AfricanAmerican |
2.131200E-01 |
| Normal-vs-Asian |
9.728000E-02 |
| Caucasian-vs-AfricanAmerican |
7.292600E-01 |
| Caucasian-vs-Asian |
5.041800E-02 |
| AfricanAmerican-vs-Asian |
1.348450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.067600E-01 |
| Normal-vs-Female |
1.292390E-02 |
| Male-vs-Female |
5.316000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.343700E-02 |
| Normal-vs-Extreme_Weight |
8.969200E-01 |
| Normal-vs-Obese |
2.069200E-01 |
| Normal-vs-Extreme_Obese |
7.328800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.334500E-02 |
| Normal_Weight-vs-Obese |
3.445400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.223200E-01 |
| Extreme_Weight-vs-Obese |
1.196800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.614800E-01 |
| Obese-vs-Extreme_Obese |
8.728600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.704100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.752810E-01 |
| Normal-vs-Age(61-80Yrs) |
1.342050E-01 |
| Normal-vs-Age(81-100Yrs) |
8.041400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.841900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.229600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.472400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.462000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.384200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.272240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.200600E-01 |
| Normal-VS-Type2 PRCC |
4.390500E-02 |
| Normal-VS-KIRP CIMP |
1.5012399999903E-05 |
| Normal-VS-Unclassified PRCC |
1.257430E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.077200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.54680054823098E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
2.528400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.847900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.469200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.035520E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.814400E-02 |
| Normal-vs-N1 |
3.609200E-04 |
| Normal-vs-N2 |
3.252200E-01 |
| N0-vs-N1 |
1.227840E-02 |
| N0-vs-N2 |
8.721400E-01 |
| N1-vs-N2 |
2.188000E-01 |
|
|
